“S” shaped organotin(IV) carboxylates based on amide carboxylic acids: Syntheses, crystal structures and antitumor activities

Investigating the structural chemistry of organotin(IV) compounds: recent advances

Organotin(IV) compounds have been considered for their outstanding industrial, medical and specific applications in the synthesis of various types of chemical compounds. In this review, we have focused on the structural chemistry of organotin(IV) compounds, including coordination chemistry, the effect of structure on reactions, bond formations from the perspective of structure and investigation of the structure of organotin(IV) compounds in different phases. The structural chemistry of organotin(IV) compounds is subject to interest due to their major impact on predicting the properties and drumming up support for pushing back the frontiers of synthesis of organotin(IV) compounds with advanced properties.

Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives

Organotins(IV) exhibit significant in vitro anti-proliferative activity, while the in vivo tests are encouraging. The recent reports on the anti-proliferative activity of organotin(IV) compounds are summarized in this review. The period covered by this work goes back to 2009 until late 2018, while the earlier ones, are included over the previous review of our group published by S.K. Hadjikakou, N. Hadjiliadis, in Coord Chem Rev, 253 (2009) 235-249. During the last decade (2009-2018), >300 organotin(IV) derivatives with oxygen-donor ligands, such as carboxylic acids, amino-acids, Non Steroidal Anti-inflammatory Drugs (NSAIDs), biological active derivatives or natural products, organotins(IV) with sulfur containing ligands such as thiones, thiosemicarbazones, dithiocarbamates, organotin(IV) compounds of oximes and organotins(IV) with amines or semicarbazones were screened for their anti-proliferative effect against various cancer cell lines and their results are included in numerous reports over this period. Although much work has been carried out on organotin(IV) derivatives with O-donor ligands, however significant fewer reports are found on organotins(IV) with oximes as ligands.